This Government Contract opportunity from Department Of Defense was posted on July 16, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

cGMP Manufacturing & Scalable Production

Closed

Federal

Submission Closed08/07/2026, 08:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

Federal

Supply of Food & Water, Gastrointestinal, Meningitis/Encephalitis, and Respiratory Panel 2.1 IVDs

Navsup Flc Sigonella Naples Office

POSTED

DEADLINE

Supply of FilmArray NGDS Sentinel Panel v3.0 (30 Tests)

Navsup Flc Sigonella Naples Office

POSTED

DEADLINE

Supply of Blood Culture Identification Panel 2 IVD (30 Tests)

Navsup Flc Sigonella Naples Office

POSTED

DEADLINE

Supply of BioFire Global Fever Special Pathogens Panel IVD (6 Tests)

Navsup Flc Sigonella Naples Office

POSTED

DEADLINE

Supply of 10x Genomics Single-Cell Capture Reagents for Chromium Platform

National Institutes Of Health Olao

POSTED

DEADLINE

Performance Testing & Proficiency Sample Management

POSTED

DEADLINE

Solicitation # 36C77026Q0166

This solicitation, identified as 36C77026Q0166, is issued by the Department of Veterans Affairs under the National CMOP Office for pharmaceutical services in Charleston. The opportunity is designated as a total small business set-aside under NAICS code 325412. The contract is managed by the office located in Leavenworth, Kansas, with the actual place of performance situated in Ladson, South Carolina. Interested parties must submit their responses by August 18, 2026, and can coordinate with the primary point of contact, Claudine Challinor.

National Cmop Office (36C770)

POSTED

DEADLINE

6505--Tacrolimus Capsules

Solicitation # 36E79726R0033

Nac Pharmaceuticals (36E797)

POSTED

DEADLINE

Solicitation # SPE2DP-26-T-4557

This contract is for the procurement of two units of technical grade Carbon Dioxide gas, USP Cylinder Type E, for the Department of Defense Medical Supply Chain. The gas must have a minimum purity of 99.5 percent, with a gas weight of 6 lbs and a total filled weight of 20 lbs without the cap, maintained at 1800 PSI. Delivery is required within five days after the order is placed. Suppliers must adhere to strict commercial packaging and packing standards to ensure the contents are protected from damage during transit. All materials must be marked according to Medical Marking Standard No. 1, which supersedes previous military standards. Bidders are required to specify the source and part number being supplied and must comply with DLA packaging and quality requirements as outlined in the master list of technical requirements.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

SUNSCREEN PREPARATION

Solicitation # SPE2DP-26-T-4631

This contract is for the procurement of SPF 30 sunscreen lotion, provided in 4.5 ounce tubes. The product must be sweatproof, waterproof, and PABA free, with a non-extendable shelf life of 36 months. The unit of issue is a package of 12 tubes, and the total order quantity is 10 packages. This item is regulated by the FDA and must adhere to Medical Marking Standard No. 1, requiring labels to include the NSN, manufacturer, CAGE code, date of manufacture, expiration or retest date, and the contract or lot number. The agreement specifies that packaging must be commercial and capable of protecting the contents from damage, with palletization following DLA packaging requirements. Delivery is set for 20 days after order, with the destination point being Gulfport, Mississippi. The contract emphasizes compliance with the DLA Master List of Technical and Quality Requirements and requires the bidder to specify the source and part number being supplied.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

LEVOTHYROXINE SODIUM T

Solicitation # SPE2DP-26-T-4625

This contract is for the procurement of Levothyroxine Sodium Tablets, USP, 100 micrograms, with a unit of issue consisting of one bottle containing 90 tablets. The medication must be stored at controlled room temperature and protected from light and moisture. It carries a non-extendable shelf life of 36 months. The order specifies delivery to the Carrier Outfitting Material Support Center in Suffolk, Virginia, with a required delivery date of August 13, 2026, and a delivery window of five days after the order. Packaging must be commercial grade, utilizing sealed unit containers and exterior shipping containers to prevent damage. All materials must be marked according to Medical Marking Standard No. 1, and shipping must be conducted via the fastest traceable means, explicitly prohibiting the use of parcel post.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-26-T-4628

This contract is for the procurement of Dibucaine Ointment, a medication containing 1 percent of dibucaine as the active ingredient. The product is intended for external rectal administration and is supplied in a collapsible tube with a rectal applicator. Each unit of issue consists of a 28 gram or one ounce package. The ointment must be stored at temperatures between 15 and 30 degrees Celsius and has a non-extendable shelf life of 36 months. The order consists of two packages under solicitation number SPE2DP-26-T-4628, with a delivery requirement of five days after the order. The product is regulated by the FDA and must adhere to DLA packaging and medical marking standards. Delivery and inspection are set as FOB destination, and the contract is managed by the Department of Defense Medical Supply Chain.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 4 days

AI Contract Overview

The contract seeks a qualified contractor to manufacture an autoinjector platform in a cGMP-compliant facility capable of scaling production to meet the demands of both military and commercial markets. The work must adhere to the highest quality standards for pharmaceutical and device manufacturing, ensuring consistency, safety, and regulatory compliance across all units produced. The facility must具备 the technical infrastructure and validated processes to support high-volume output while maintaining strict control over raw materials, assembly, sterilization, and packaging, all tailored to fulfill the specific requirements of defense and public health applications. Performance is designated to take place in Gunpowder, Maryland, with a response deadline of August 7, 2026, and the solicitation is categorized as a subcontract under NAICS code 325412 for pharmaceutical preparation manufacturing. The contract is issued by the Department of Defense through the W6QK Acc-Apg office, indicating its strategic relevance to national defense medical readiness. While not subject to a specific set-aside classification, the opportunity is open to entities with demonstrated capability in sterile, high-reliability manufacturing, particularly those experienced in serving government agencies with stringent quality and traceability demands.